Clinical

Dataset Information

0

Medical Records Based Real-World Study of Cetuximab in Combination with FOLFIRI Regimen as First-Line Chemotherapy and Subsequent Cetuximab-based Maintenance Therapy for the Maintenance Treatment of Patients with RAS and BRAF Wild-Type Unresectable Metastatic Colorectal Cancer


ABSTRACT: Interventions: Maintenance group:Nil Primary outcome(s): Progression Free Survival;Adverse Events;Failure-free survival Study Design: Sequential

DISEASE(S): Colorectal Cancer

PROVIDER: 2701129 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 96797 | ecrin-mdr-crc
| 2689050 | ecrin-mdr-crc
| PRJNA158491 | ENA